Literature DB >> 22957757

Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function.

M Bucci1, V Vellecco, L Harrington, V Brancaleone, F Roviezzo, G Mattace Raso, A Ianaro, G Lungarella, R De Palma, R Meli, G Cirino.   

Abstract

BACKGROUND AND
PURPOSE: Proteinase-activated receptors (PARs) and toll-like receptors (TLRs) are involved in innate immune responses. The aim of this study was to evaluate the possible cross-talk between PAR(2) and TLR4 in vessels in physiological condition and how it varies following stimulation of TLR4 by using in vivo and ex vivo models. EXPERIMENTAL APPROACH: Thoracic aortas were harvested from both naïve and endotoxaemic rats for in vitro studies. Arterial blood pressure was monitored in anaesthetized rats in vivo. LPS was used as a TLR4 agonist while PAR(2) activating peptide (AP) was used as a PAR(2) agonist. Aortas harvested from TLR4(-/-) mice were also used to characterize the PAR(2) response. KEY
RESULTS: PAR(2) , but not TLR4, expression was enhanced in aortas of endotoxaemic rats. PAR(2) AP-induced vasorelaxation was increased in aortic rings of LPS-treated rats. TLR4 inhibitors, curcumine and resveratrol, reduced PAR(2) AP-induced vasorelaxation and PAR(2) AP-induced hypotension in both naïve and endotoxaemic rats. Finally, in aortic rings from TLR4(-/-) mice, the expression of PAR(2) was reduced and the PAR(2) AP-induced vasodilatation impaired compared with those from wild-type mice and both resveratrol and curcumine were ineffective. CONCLUSIONS AND IMPLICATIONS: Cross-talk between PAR(2) and TLR4 contributes to vascular homeostasis.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22957757      PMCID: PMC3572567          DOI: 10.1111/j.1476-5381.2012.02205.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

Review 1.  Mammalian toll-like receptors: from endogenous ligands to tissue regeneration.

Authors:  Z Zhang; H J Schluesener
Journal:  Cell Mol Life Sci       Date:  2006-12       Impact factor: 9.261

Review 2.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 3.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

4.  A protective role for proteinase activated receptor 2 in airways of lipopolysaccharide-treated rats.

Authors:  Silvana Morello; Valentina Vellecco; Fiorentina Roviezzo; Pasquale Maffia; Salvatore Cuzzocrea; Giuseppe Cirino; Carla Cicala
Journal:  Biochem Pharmacol       Date:  2005-11-21       Impact factor: 5.858

5.  Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2.

Authors:  Yutaka Kida; Hiroyoshi Inoue; Takashi Shimizu; Koichi Kuwano
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

6.  Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism.

Authors:  Naokazu Nakamura; Masayuki Yoshida; Makoto Umeda; Yi Huang; Shigetaka Kitajima; Yoshinori Inoue; Isao Ishikawa; Takehisa Iwai
Journal:  Atherosclerosis       Date:  2007-03-19       Impact factor: 5.162

7.  Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection.

Authors:  Marinella Holzhausen; Luis Carlos Spolidorio; Richard P Ellen; Marie-Claude Jobin; Martin Steinhoff; Patricia Andrade-Gordon; Nathalie Vergnolle
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

8.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Inhibition of homodimerization of Toll-like receptor 4 by curcumin.

Authors:  Hyung S Youn; Shin I Saitoh; Kensuke Miyake; Daniel H Hwang
Journal:  Biochem Pharmacol       Date:  2006-04-01       Impact factor: 5.858

Review 10.  Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease.

Authors:  Jane A Mitchell; Mark J Paul-Clark; Graham W Clarke; Shaun K McMaster; Neil Cartwright
Journal:  J Endocrinol       Date:  2007-06       Impact factor: 4.286

View more
  9 in total

1.  PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.

Authors:  Shannon M Jones; Adrien Mann; Kelsey Conrad; Keith Saum; David E Hall; Lisa M McKinney; Nathan Robbins; Joel Thompson; Abigail D Peairs; Eric Camerer; Katey J Rayner; Michael Tranter; Nigel Mackman; A Phillip Owens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

2.  Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function.

Authors:  Yutong Zhao; Jing Zhao; Rachel K Mialki; Jianxin Wei; Ernst W Spannhake; Ravi Salgia; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-26       Impact factor: 5.464

3.  EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.

Authors:  Hai Po H Liang; Edward J Kerschen; Irene Hernandez; Sreemanti Basu; Mark Zogg; Fady Botros; Shuang Jia; Martin J Hessner; John H Griffin; Wolfram Ruf; Hartmut Weiler
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

Review 4.  Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.

Authors:  Frank Gieseler; Hendrik Ungefroren; Utz Settmacher; Morley D Hollenberg; Roland Kaufmann
Journal:  Cell Commun Signal       Date:  2013-11-11       Impact factor: 5.712

5.  Can the TLR-4-mediated signaling pathway be "a key inflammatory promoter for sporadic TAA"?

Authors:  Giovanni Ruvolo; Calogera Pisano; Giuseppina Candore; Domenico Lio; Cesira Palmeri; Emiliano Maresi; Carmela R Balistreri
Journal:  Mediators Inflamm       Date:  2014-07-10       Impact factor: 4.711

6.  Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells.

Authors:  Hung-Hsing Chao; Po-Yuan Chen; Wen-Rui Hao; Wei-Ping Chiang; Tzu-Hurng Cheng; Shih-Hurng Loh; Yuk-Man Leung; Ju-Chi Liu; Jin-Jer Chen; Li-Chin Sung
Journal:  J Biomed Sci       Date:  2017-11-15       Impact factor: 8.410

7.  The interaction effects between TLR4 and MMP9 gene polymorphisms contribute to aortic aneurysm risk in a Chinese Han population.

Authors:  Tan Li; Xu Zhang; Liang Sang; Xin-Tong Li; Hai-Yang Sun; Jun Yang; Yuan Yuan
Journal:  BMC Cardiovasc Disord       Date:  2019-03-29       Impact factor: 2.298

Review 8.  Diversification of PAR signaling through receptor crosstalk.

Authors:  Irene Lee-Rivera; Edith López; Ana María López-Colomé
Journal:  Cell Mol Biol Lett       Date:  2022-09-10       Impact factor: 8.702

9.  The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia.

Authors:  Naveen Gupta; Ranjeet Sinha; Anna Krasnodembskaya; Xiao Xu; Victor Nizet; Michael A Matthay; John H Griffin
Journal:  Stem Cells       Date:  2018-02-14       Impact factor: 6.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.